Lexaria Bioscience Corp. (LEXX) earnings
Quarterly results of Lexaria Bioscience Corp. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Lexaria Bioscience Corp. is expected to report around November 27, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Latest quarter: Q3 FY2026
In Q3 FY2026 (ended May 31, 2026) Lexaria Bioscience Corp. reported revenue of $0 and a net loss of $2M.
Diluted earnings per share were -$0.08.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q3 FY2026 | $0 | - | -$2M | -$0.08 |
| Q2 FY2026 | $20K | -88.5% | -$1.4M | -$0.06 |
| Q1 FY2026 | $0 | - | -$1.6M | -$0.07 |
| Q4 FY2025 | $174K | +107.1% | -$2.7M | - |
| Q3 FY2025 | $174K | - | -$3.8M | -$0.21 |
| Q2 FY2025 | $174K | - | -$2.7M | -$0.15 |
| Q1 FY2025 | $183.9K | - | -$2.7M | -$0.16 |
| Q4 FY2024 | $84K | - | -$2.2M | - |
Results filings
- Quarterly report 10-Q
- Quarterly report 10-Q
- Quarterly report 10-Q
- Annual report 10-K
When is Lexaria Bioscience Corp.'s next earnings date?
Lexaria Bioscience Corp. is expected to report around November 27, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
What were Lexaria Bioscience Corp.'s latest quarterly results?
For Q3 FY2026, which ended May 31, 2026, Lexaria Bioscience Corp. reported revenue of $0 and a net loss of $2M. The figures come from its filing with the SEC.
Get an email when LEXX reports
Follow LEXX and we email you its next results the day they are filed, with the numbers explained.